| |
|
|
|
|
|
|
|||
|
Blood, 1 February 2006, Vol. 107, No. 3, pp. 855-856.
Stem cell markers: less is more!UNIVERSITY OF KENTUCKY SCHOOL OF MEDICINE
Yilmaz and colleagues present a simplified technique for the prospective identification and purification of hematopoietic stem cells; unlike previous methods, their method is effective in a variety of contexts, including old marrow, mobilized peripheral blood, and recipients of long-term engrafted transplants.
Heretofore, typical methods have relied on a combination of up to 10 cell-surface markers to characterize hematopoietic stem cells. Despite its difficulty and nuances, this technique has been in successful practice, and has advanced our understanding of stem cell biology, since its original publication in 1988.2 As interest in hematopoietic stem cells from different aged animals and from different hematopoietic sources has grown, limitations have become apparent, the most significant of which has been the issue of whether the stem cell markers that were used maintained their stem-cell fidelity. In earlier studies, Morrison et al showed that the same technique that yielded a population in which 1 in every 5 cells purified from young bone marrow had long-term engrafting potential yielded dramatically lower purities of functional stem cells from other sources.3,4 The disparity in apparent purities could be attributable to several possibilities. One is that expression of the traditional panel of markers is altered on cells either during aging, mobilization, or prior transplantation such that the staining profile is no longer inclusive of stem cells and/or is no longer exclusive of contaminating cells. A second possibility is that the requisite steps leading to long-term engraftmentthat is, homing of stem cells to the marrow and the maintenance of long-term hematopoiesisare less efficient in stem cells derived from contexts other than young bone marrow. Compelling data in the present paper demonstrate that the bulk of the disparity is accounted for by the presence of cells in the population identified as stem cells (Lin-, Sca-1+, c-Kit+, Thy1lo) that demonstrably lack stem cell function. In contrast, the population of CD150+, CD48- cells from all hematopoietic sources tested showed dramatically improved stem-cell purities, although not quite to the highest level of enrichment obtained in populations purified from young bone marrow. With respect to aged stem cells, the difference between apparent young and old purities is probably accounted for by an approximately 3-fold less efficient homing of old stem cells to the marrow microenvironment.3,5
The findings of Yilmaz et al should significantly simplify stem cell purification, while at the same time improving purity. The results also raise important considerations for studies in which stem cells purified from different contexts are contrasted. For example, in comparing gene or protein expression profiles between stem cells from mice of different ages, it is crucial that the populations compared contain equivalent enrichments for cells with stem cell function. Purifications using the proper SLAM code should ensure that apples are compared to apples. References
Related Article in Blood Online:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||